Overview

Intracoronary Tirofiban on No-Reflow Phenomena

Status:
Completed

Trial end date:
2013-12-01

Target enrollment:

Participant gender:

Summary

The goal of this study was to evaluate the acute effect of intracoronary administration of tirofiban on no-reflow phenomenon in patients with STEMI and occurrence of no-reflow phenomenon undergoing primary percutaneous coronary intervention (PCI).

Phase:

Phase 4

Details

Lead Sponsor:

TC Erciyes University

Treatments:

Tirofiban